Per Nørgaard
Novo Nordisk
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Per Nørgaard.
Journal of Biological Chemistry | 2011
Waseem Sajid; Nikolaj Kulahin; Gerd Schluckebier; Ulla Ribel; Hope R. Henderson; Marc Tatar; Bo Falck Hansen; Angela Manegold Svendsen; Vladislav V. Kiselyov; Per Nørgaard; Per-Olof Wahlund; Jakob Brandt; Ronald A. Kohanski; Asser Sloth Andersen; Pierre De Meyts
We report the crystal structure of two variants of Drosophila melanogaster insulin-like peptide 5 (DILP5) at a resolution of 1.85 Å. DILP5 shares the basic fold of the insulin peptide family (T conformation) but with a disordered B-chain C terminus. DILP5 dimerizes in the crystal and in solution. The dimer interface is not similar to that observed in vertebrates, i.e. through an anti-parallel β-sheet involving the B-chain C termini but, in contrast, is formed through an anti-parallel β-sheet involving the B-chain N termini. DILP5 binds to and activates the human insulin receptor and lowers blood glucose in rats. It also lowers trehalose levels in Drosophila. Reciprocally, human insulin binds to the Drosophila insulin receptor and induces negative cooperativity as in the human receptor. DILP5 also binds to insect insulin-binding proteins. These results show high evolutionary conservation of the insulin receptor binding properties despite divergent insulin dimerization mechanisms.
Applied Microbiology and Biotechnology | 2013
Ali Kazemi Seresht; Per Nørgaard; Eva Palmqvist; Asser Sloth Andersen; Lisbeth Olsson
The use of auxotrophic Saccharomyces cerevisiae strains for improved production of a heterologous protein was examined. Two different marker genes were investigated, encoding key enzymes in the metabolic pathways for amino acid (LEU2) and pyrimidine (URA3) biosynthesis, respectively. Expression plasmids, carrying the partly defective selection markers LEU2d and URA3d, were constructed. Two CEN.PK-derived strains were chosen and insulin analogue precursor was selected as a model protein. Different truncations of the LEU2 and URA3 promoters were used as the mean to titrate the plasmid copy number and thus the recombinant gene dosage in order to improve insulin productivity. Experiments were initially carried out in batch mode to examine the stability of yeast transformants and to select high yielding mutants. Next, chemostat cultivations were run at high cell density to address industrial applicability and long-term expression stability of the transformants. We found that the choice of auxotrophic marker is crucial for developing a yeast expression system with stable heterologous protein production. The incremental truncation of the URA3 promoter led to higher plasmid copy numbers and IAP yields, whereas the truncation of the LEU2 promoter caused low plasmid stability. We show that the modification of the level of the recombinant gene dosage by varying the degree of promoter truncation can be a strong tool for optimization of productivity. The application of the URA3d-based expression systems showed a high potential for industrial protein production and for further academic studies.
Yeast | 2003
Per Nørgaard; Christine Tachibana; Anette W. Bruun; Jakob R. Winther
We have examined the activities of promoters of a number of yeast genes encoding resident endoplasmic reticulum proteins, and found increased expression in a strain with severe protein disulphide isomerase deficiency. Serial deletion in the promoter of the MPD1 gene, which encodes a PDI1‐homologue, revealed a cis‐acting element responding to deficiency of protein disulphide isomerase activity (designated CERP). The presence of the sequence element is necessary and sufficient for the upregulation in response to disulphide isomerase deficiency, as measured by a minimal promoter containing the CERP element. The sequence (GACACG) does not resemble the unfolded protein response element. It is present in the upstream regions of the MPD1, MPD2, KAR2, PDI1 and ERO1 genes. Copyright
Journal of Cell Biology | 2001
Per Nørgaard; Vibeke Westphal; Christine Tachibana; Lene Alsøe; Bjørn Holst; Jakob R. Winther
Analytical Biochemistry | 2007
Rosa E. Hansen; Henrik Østergaard; Per Nørgaard; Jakob R. Winther
Archive | 2007
Peter Kresten Nielsen; Frantisek Hubalek; Inger Lautrup-Larsen; Svend Ludvigsen; Ulla Ribel-Madsen; Per Balschmidt; Per Nørgaard; Svend Havelund
Biochemical Journal | 2001
Per Nørgaard; Jakob R. Winther
Archive | 2007
Per Nørgaard; Andersen Asser Sloth
Archive | 2010
Asser Sloth Andersen; Inger Lautrup-Larsen; Per Nørgaard
Archive | 2007
Per Nørgaard